Breton Hill Capital Ltd. buys $6,985,616 stake in HCP (HCP)

HCP (HCP) : Breton Hill Capital Ltd. scooped up 27,579 additional shares in HCP during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 12, 2016. The investment management firm now holds a total of 199,989 shares of HCP which is valued at $6,985,616.HCP makes up approximately 2.56% of Breton Hill Capital Ltd.’s portfolio.

HCP closed down -0.12 points or -0.34% at $34.93 with 34,68,636 shares getting traded on Friday. Post opening the session at $35.03, the shares hit an intraday low of $34.71 and an intraday high of $35.16 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Other Hedge Funds, Including , Hexavest reduced its stake in HCP by selling 18,672 shares or 1.39% in the most recent quarter. The Hedge Fund company now holds 1,327,133 shares of HCP which is valued at $46,356,756. HCP makes up approx 0.72% of Hexavest’s portfolio.Dnb Asset Management As boosted its stake in HCP in the latest quarter, The investment management firm added 11,800 additional shares and now holds a total of 36,966 shares of HCP which is valued at $1,291,222. HCP makes up approx 0.03% of Dnb Asset Management As’s portfolio.Kistler-tiffany Companies reduced its stake in HCP by selling 99 shares or 26.54% in the most recent quarter. The Hedge Fund company now holds 274 shares of HCP which is valued at $9,502. HCP makes up approx 0.01% of Kistler-tiffany Companies’s portfolio.Chevy Chase Trust Holdings boosted its stake in HCP in the latest quarter, The investment management firm added 8,968 additional shares and now holds a total of 396,006 shares of HCP which is valued at $13,733,488. HCP makes up approx 0.08% of Chevy Chase Trust Holdings’s portfolio. Chelsea Counsel Co sold out all of its stake in HCP during the most recent quarter. The investment firm sold 7,215 shares of HCP which is valued $250,216.

On the company’s financial health, HCP reported $0.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Feb 9, 2016. Analyst had a consensus of $0.78. The company had revenue of $668.00 million for the quarter, compared to analysts expectations of $641.48 million. The company’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. UBS Downgraded HCP on Mar 16, 2016 to ” Neutral”, Price Target of the shares are set at $31.Shares were Reiterated by Barclays on Mar 10, 2016 to “Underweight” and Lowered the Price Target to $ 33 from a previous price target of $37 .Stifel Downgraded HCP on Feb 11, 2016 to ” Sell”, Price Target of the shares are set at $23.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Leave a Reply

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.